| Year |
Citation |
Score |
| 2020 |
Winger G, Jutkiewicz EM, Woods JH. Comparison of the muscarinic antagonist effects of scopolamine and L-687,306. Behavioural Pharmacology. PMID 31922966 DOI: 10.1097/Fbp.0000000000000537 |
0.635 |
|
| 2020 |
Smith HR, Zamora JC, Chavera TS, Jennings EM, Winger GD, Woods JH, Clarke WP, Berg KA. Agonist‐Dependent Modulation by the Long‐Acting Mu Opioid Receptor Antagonist, Methocinnamox (MCAM) The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.06832 |
0.424 |
|
| 2019 |
Zamora JC, Kotipalli V, Jennings EM, Disney A, Husbands S, Winger G, Clarke WP, Woods JH, Berg KA. Methocinnamox (MCAM) is a Selective, Long Acting Antagonist at Mu Opioid Receptors In Vitro The Faseb Journal. 33. DOI: 10.1096/Fasebj.2019.33.1_Supplement.498.8 |
0.427 |
|
| 2018 |
Gerak LR, Maguire DR, Woods JH, Husbands SM, Disney A, France CP. Reversal and prevention of the respiratory-depressant effects of heroin by the novel µ opioid receptor antagonist methocinnamox in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 30463875 DOI: 10.1124/Jpet.118.253286 |
0.757 |
|
| 2018 |
Maguire DR, Gerak LR, Woods JH, Husbands SM, Disney A, France CP. Long-lasting effects of methocinnamox on heroin self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 30401680 DOI: 10.1124/Jpet.118.252353 |
0.79 |
|
| 2016 |
Saccone PA, Lindsey AM, Koeppe RA, Zelenock KA, Shao X, Sherman P, Quesada CA, Woods JH, Scott PJ. Intranasal opioid administration in rhesus monkeys: PET imaging and antinociception. The Journal of Pharmacology and Experimental Therapeutics. PMID 27625351 DOI: 10.1124/Jpet.116.235192 |
0.454 |
|
| 2016 |
Saccone PA, Zelenock KA, Linsdey AM, Sulima A, Rice KC, Prinssen EP, Wichmann J, Woods JH. Characterization of the discriminative stimulus effects of a NOP receptor agonist Ro 64-6198 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 26801398 DOI: 10.1124/Jpet.115.231134 |
0.346 |
|
| 2015 |
Bertz JW, Jackson EL, Barron DR, Woods JH. Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer. Behavioural Pharmacology. PMID 26580131 DOI: 10.1097/FBP.0000000000000205 |
0.411 |
|
| 2015 |
Bertz JW, Chen J, Woods JH. Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat. Psychopharmacology. 232: 209-21. PMID 24985891 DOI: 10.1007/s00213-014-3659-2 |
0.303 |
|
| 2015 |
Saccone PA, Zelenock KA, Lindsey A, Zaks ME, Woods JH. Characterization of the discriminative stimulus effects of the NOP agonist Ro 64-6198 in non-human primates Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.603 |
0.33 |
|
| 2015 |
Bertz JW, Woods JH. Effects of sex and remifentanil dose on the acquisition of responding for a remifentanil-associated stimulus Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.074 |
0.313 |
|
| 2014 |
Howell L, Nye J, Stehouwer J, Voll R, Mun J, Narasimhan D, Nichols J, Sunahara R, Goodman M, Carroll F, Woods J. Effects of a mutant bacterial cocaine esterase on cocaine brain levels measured with pet neuroimaging in rhesus monkeys Drug and Alcohol Dependence. 140: e92-e93. DOI: 10.1016/J.Drugalcdep.2014.02.269 |
0.386 |
|
| 2013 |
Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JH. Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neuroscience Letters. 552: 98-102. PMID 23933210 DOI: 10.1016/j.neulet.2013.07.040 |
0.362 |
|
| 2013 |
Bertz JW, Woods JH. Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat. Psychopharmacology. 229: 235-43. PMID 23609770 DOI: 10.1007/s00213-013-3102-0 |
0.376 |
|
| 2013 |
Jutkiewicz EM, Rice KC, Carroll FI, Woods JH. Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats. Drug and Alcohol Dependence. 131: 284-97. PMID 23333294 DOI: 10.1016/J.Drugalcdep.2012.12.021 |
0.628 |
|
| 2013 |
Koffarnus MN, Woods JH. Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose. Addiction Biology. 18: 8-18. PMID 21812874 DOI: 10.1111/J.1369-1600.2011.00361.X |
0.686 |
|
| 2012 |
Moynihan HA, Derrick I, Broadbear JH, Greedy BM, Aceto MD, Harris LS, Purington LC, Thomas MP, Woods JH, Traynor JR, Husbands SM, Lewis JW. Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects. Journal of Medicinal Chemistry. 55: 9868-74. PMID 23043264 DOI: 10.1021/jm301096s |
0.4 |
|
| 2012 |
Koffarnus MN, Collins GT, Rice KC, Chen J, Woods JH, Winger G. Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys. Behavioural Pharmacology. 23: 331-8. PMID 22785383 DOI: 10.1097/Fbp.0B013E3283564Dbb |
0.777 |
|
| 2012 |
Collins GT, Brim RL, Noon KR, Narasimhan D, Lukacs NW, Sunahara RK, Woods JH, Ko MC. Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 342: 205-13. PMID 22518021 DOI: 10.1124/Jpet.112.194639 |
0.815 |
|
| 2012 |
Lee TY, Park YS, Garcia GA, Sunahara RK, Woods JH, Yang VC. Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination. Molecular Pharmaceutics. 9: 1361-73. PMID 22404344 DOI: 10.1021/Mp200623W |
0.379 |
|
| 2012 |
Narasimhan D, Woods JH, Sunahara RK. Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction. Future Medicinal Chemistry. 4: 137-50. PMID 22300094 DOI: 10.4155/Fmc.11.194 |
0.404 |
|
| 2012 |
Collins GT, Narasimhan D, Cunningham AR, Zaks ME, Nichols J, Ko MC, Sunahara RK, Woods JH. Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1092-103. PMID 21993206 DOI: 10.1038/Npp.2011.226 |
0.69 |
|
| 2012 |
Brim RL, Noon KR, Collins GT, Stein A, Nichols J, Narasimhan D, Ko MC, Woods JH, Sunahara RK. The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination. The Journal of Pharmacology and Experimental Therapeutics. 340: 83-95. PMID 21990608 DOI: 10.1124/Jpet.111.186049 |
0.819 |
|
| 2012 |
Collins GT, Cunningham AR, Chen J, Wang S, Newman AH, Woods JH. Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats. Psychopharmacology. 219: 123-35. PMID 21701814 DOI: 10.1007/S00213-011-2382-5 |
0.698 |
|
| 2011 |
Chen J, Collins GT, Levant B, Woods J, Deschamps JR, Wang S. CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist. Acs Medicinal Chemistry Letters. 2: 620-625. PMID 22125662 DOI: 10.1021/Ml200100T |
0.623 |
|
| 2011 |
Jimenez-Gomez C, Osentoski A, Woods JH. Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. Behavioural Pharmacology. 22: 711-3. PMID 21921841 DOI: 10.1097/Fbp.0B013E32834Afebe |
0.728 |
|
| 2011 |
Narasimhan D, Collins GT, Nance MR, Nichols J, Edwald E, Chan J, Ko MC, Woods JH, Tesmer JJ, Sunahara RK. Subunit stabilization and polyethylene glycolation of cocaine esterase improves in vivo residence time. Molecular Pharmacology. 80: 1056-65. PMID 21890748 DOI: 10.1124/Mol.111.074997 |
0.655 |
|
| 2011 |
Brim RL, Noon KR, Collins GT, Nichols J, Narasimhan D, Sunahara RK, Woods JH. The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry. Molecular Pharmacology. 80: 1119-27. PMID 21885621 DOI: 10.1124/Mol.111.074534 |
0.812 |
|
| 2011 |
Brim RL, Noon KR, Nichols J, Narasimhan D, Woods JH, Sunahara RK. Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs. Drug and Alcohol Dependence. 119: 224-8. PMID 21775073 DOI: 10.1016/J.Drugalcdep.2011.06.018 |
0.824 |
|
| 2011 |
Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH. Patterns of nicotinic receptor antagonism: nicotine discrimination studies. The Journal of Pharmacology and Experimental Therapeutics. 339: 194-202. PMID 21730011 DOI: 10.1124/Jpet.111.182170 |
0.643 |
|
| 2011 |
Koffarnus MN, Newman AH, Grundt P, Rice KC, Woods JH. Effects of selective dopaminergic compounds on a delay-discounting task. Behavioural Pharmacology. 22: 300-11. PMID 21694584 DOI: 10.1097/Fbp.0B013E3283473Bcb |
0.675 |
|
| 2011 |
Collins GT, Zaks ME, Cunningham AR, St Clair C, Nichols J, Narasimhan D, Ko MC, Sunahara RK, Woods JH. Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. Drug and Alcohol Dependence. 118: 158-65. PMID 21481548 DOI: 10.1016/J.Drugalcdep.2011.03.015 |
0.689 |
|
| 2011 |
Collins GT, Carey KA, Narasimhan D, Nichols J, Berlin AA, Lukacs NW, Sunahara RK, Woods JH, Ko MC. Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1047-59. PMID 21289605 DOI: 10.1038/Npp.2010.242 |
0.691 |
|
| 2011 |
Collins GT, Truong YN, Levant B, Chen J, Wang S, Woods JH. Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity. Psychopharmacology. 215: 609-20. PMID 21207013 DOI: 10.1007/S00213-010-2154-7 |
0.65 |
|
| 2011 |
Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH. Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys. Behavioural Pharmacology. 22: 87-90. PMID 21160425 DOI: 10.1097/Fbp.0B013E3283423D55 |
0.779 |
|
| 2011 |
Xue L, Ko MC, Tong M, Yang W, Hou S, Fang L, Liu J, Zheng F, Woods JH, Tai HH, Zhan CG. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Molecular Pharmacology. 79: 290-7. PMID 20971807 DOI: 10.1124/mol.110.068494 |
0.43 |
|
| 2011 |
Podlesnik CA, Ko MC, Winger G, Wichmann J, Prinssen EP, Woods JH. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys. Psychopharmacology. 213: 53-60. PMID 20852848 DOI: 10.1007/S00213-010-2012-7 |
0.724 |
|
| 2011 |
Bergman J, Woods JH. Charles Roberts Schuster Neuropsychopharmacology. 36: 2782-2782. DOI: 10.1038/Npp.2011.71 |
0.315 |
|
| 2011 |
Koek W, Woods JH, France CP. Obituary: Francis C. Colpaert, Ph.D. (1950-2010) Psychopharmacology. 1-2. DOI: 10.1007/S00213-011-2179-6 |
0.46 |
|
| 2010 |
Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nuclear Medicine and Biology. 37: 989-96. PMID 21055630 DOI: 10.1016/J.Nucmedbio.2010.06.002 |
0.577 |
|
| 2010 |
Podlesnik CA, Jimenez-Gomez C, Woods JH. A choice procedure to assess the aversive effects of drugs in rodents. Journal of the Experimental Analysis of Behavior. 93: 203-23. PMID 20885811 DOI: 10.1901/Jeab.2010.93-203 |
0.809 |
|
| 2010 |
Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. The Journal of Pharmacology and Experimental Therapeutics. 335: 728-34. PMID 20858706 DOI: 10.1124/Jpet.110.172247 |
0.638 |
|
| 2010 |
Cooper ZD, Shi YG, Woods JH. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology. 212: 369-78. PMID 20686752 DOI: 10.1007/S00213-010-1966-9 |
0.727 |
|
| 2010 |
Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Behavioural Pharmacology. 21: 171-81. PMID 20463460 DOI: 10.1097/Fbp.0B013E32833A5C68 |
0.625 |
|
| 2010 |
Narasimhan D, Nance MR, Gao D, Ko MC, Macdonald J, Tamburi P, Yoon D, Landry DM, Woods JH, Zhan CG, Tesmer JJ, Sunahara RK. Structural analysis of thermostabilizing mutations of cocaine esterase. Protein Engineering, Design & Selection : Peds. 23: 537-47. PMID 20436035 DOI: 10.1093/Protein/Gzq025 |
0.414 |
|
| 2010 |
Brim RL, Nance MR, Youngstrom DW, Narasimhan D, Zhan CG, Tesmer JJ, Sunahara RK, Woods JH. A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse. Molecular Pharmacology. 77: 593-600. PMID 20086035 DOI: 10.1124/Mol.109.060806 |
0.815 |
|
| 2010 |
Park JB, Kwon YM, Lee TY, Brim R, Ko MC, Sunahara RK, Woods JH, Yang VC. PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 174-9. PMID 19857534 DOI: 10.1016/J.Jconrel.2009.10.015 |
0.811 |
|
| 2010 |
Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH. Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug and Alcohol Dependence. 106: 219-29. PMID 19800183 DOI: 10.1016/J.Drugalcdep.2009.09.001 |
0.769 |
|
| 2010 |
Jutkiewicz EM, Baladi MG, Cooper ZD, Woods JH. In reply Annals of Emergency Medicine. 55: 485-486. DOI: 10.1016/j.annemergmed.2009.11.028 |
0.742 |
|
| 2009 |
Nieland NP, Rennison D, Broadbear JH, Purington L, Woods JH, Traynor JR, Lewis JW, Husbands SM. 14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists. Journal of Medicinal Chemistry. 52: 6926-30. PMID 19842669 DOI: 10.1021/Jm901074A |
0.36 |
|
| 2009 |
Collins GT, Brim RL, Narasimhan D, Ko MC, Sunahara RK, Zhan CG, Woods JH. Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 331: 445-55. PMID 19710369 DOI: 10.1124/Jpet.108.150029 |
0.826 |
|
| 2009 |
Collins GT, Woods JH. Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats. Behavioural Pharmacology. 20: 492-504. PMID 19696656 DOI: 10.1097/Fbp.0B013E328330Ad9B |
0.687 |
|
| 2009 |
Ko MC, Woods JH, Fantegrossi WE, Galuska CM, Wichmann J, Prinssen EP. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2088-96. PMID 19279568 DOI: 10.1038/npp.2009.33 |
0.722 |
|
| 2009 |
Moynihan H, Jales AR, Greedy BM, Rennison D, Broadbear JH, Purington L, Traynor JR, Woods JH, Lewis JW, Husbands SM. 14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity. Journal of Medicinal Chemistry. 52: 1553-7. PMID 19253983 DOI: 10.1021/Jm8012272 |
0.422 |
|
| 2009 |
Ko MC, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Woods JH. Effects of cocaine esterase following its repeated administration with cocaine in mice. Drug and Alcohol Dependence. 101: 202-9. PMID 19217723 DOI: 10.1016/J.Drugalcdep.2009.01.002 |
0.455 |
|
| 2009 |
Collins GT, Truccone A, Haji-Abdi F, Newman AH, Grundt P, Rice KC, Husbands SM, Greedy BM, Enguehard-Gueiffier C, Gueiffier A, Chen J, Wang S, Katz JL, Grandy DK, Sunahara RK, ... Woods JH, et al. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice. The Journal of Pharmacology and Experimental Therapeutics. 329: 210-7. PMID 19136638 DOI: 10.1124/Jpet.108.144048 |
0.622 |
|
| 2009 |
Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH. A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Annals of Emergency Medicine. 54: 409-20. PMID 19013687 DOI: 10.1016/J.Annemergmed.2008.09.023 |
0.814 |
|
| 2009 |
Gao D, Narasimhan DL, Macdonald J, Brim R, Ko MC, Landry DW, Woods JH, Sunahara RK, Zhan CG. Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Molecular Pharmacology. 75: 318-23. PMID 18987161 DOI: 10.1124/Mol.108.049486 |
0.809 |
|
| 2009 |
Koffarnus MN, Greedy B, Husbands SM, Grundt P, Newman AH, Woods JH. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats. Psychopharmacology. 203: 317-27. PMID 18807248 DOI: 10.1007/S00213-008-1323-4 |
0.687 |
|
| 2008 |
Collins GT, Woods JH. Narrowing in on compulsions: dopamine receptor functions. Experimental and Clinical Psychopharmacology. 16: 498-502. PMID 19086770 DOI: 10.1037/A0014190 |
0.661 |
|
| 2008 |
Chen J, Collins GT, Zhang J, Yang CY, Levant B, Woods J, Wang S. Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile. Journal of Medicinal Chemistry. 51: 5905-8. PMID 18785726 DOI: 10.1021/Jm800471H |
0.616 |
|
| 2008 |
Zheng F, Yang W, Ko MC, Liu J, Cho H, Gao D, Tong M, Tai HH, Woods JH, Zhan CG. Most efficient cocaine hydrolase designed by virtual screening of transition states. Journal of the American Chemical Society. 130: 12148-55. PMID 18710224 DOI: 10.1021/ja803646t |
0.374 |
|
| 2008 |
Cooper ZD, Truong YN, Shi YG, Woods JH. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. The Journal of Pharmacology and Experimental Therapeutics. 326: 920-9. PMID 18515643 DOI: 10.1124/Jpet.108.139196 |
0.717 |
|
| 2008 |
Xie H, Woods JH, Traynor JR, Ko MC. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Anesthesia and Analgesia. 106: 1873-81. PMID 18499626 DOI: 10.1213/ane.0b013e31817300be |
0.41 |
|
| 2008 |
Koffarnus MN, Woods JH. Quantification of drug choice with the generalized matching law in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 89: 209-24. PMID 18422019 DOI: 10.1901/Jeab.2008.89-209 |
0.681 |
|
| 2008 |
Pascoe JE, Williams KL, Mukhopadhyay P, Rice KC, Woods JH, Ko MC. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology. 33: 478-86. PMID 18325678 DOI: 10.1016/J.Psyneuen.2008.01.006 |
0.48 |
|
| 2008 |
Collins GT, Calinski DM, Newman AH, Grundt P, Woods JH. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects. The Journal of Pharmacology and Experimental Therapeutics. 325: 691-7. PMID 18305018 DOI: 10.1124/Jpet.107.133181 |
0.648 |
|
| 2008 |
Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R, Traynor JR, Woods JH. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 151: 533-43. PMID 18082974 DOI: 10.1016/J.Neuroscience.2007.11.007 |
0.801 |
|
| 2008 |
Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats. The Journal of Pharmacology and Experimental Therapeutics. 324: 714-24. PMID 17986650 DOI: 10.1124/Jpet.107.123844 |
0.825 |
|
| 2008 |
Metcalf MD, Aceto MD, Harris LS, Woods JH, Traynor JR, Coop A, May EL. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73. PMID 17962026 DOI: 10.1016/j.bmc.2007.10.030 |
0.354 |
|
| 2008 |
Kilbourn MR, Donnelly D, Husbands S, Greedy B, Woods J, Traynor J. Synthesis and in vivo PET imaging studies with [11C]BU4033, a potential delta opioid imaging agent Neuroimage. 41: T23. DOI: 10.1016/J.Neuroimage.2008.04.197 |
0.521 |
|
| 2007 |
Wood SK, Woods JH. Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances. Expert Opinion On Therapeutic Targets. 11: 1401-13. PMID 18028006 DOI: 10.1517/14728222.11.11.1401 |
0.586 |
|
| 2007 |
Chadman KK, Woods JH, Stitzel J. Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 927-36. PMID 17763108 DOI: 10.1080/14622200701540838 |
0.696 |
|
| 2007 |
Lee H, Naughton NN, Woods JH, Ko MC. Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology. 107: 478-85. PMID 17721251 DOI: 10.1097/01.anes.0000278876.20263.a7 |
0.492 |
|
| 2007 |
Collins GT, Woods JH. Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat. The Journal of Pharmacology and Experimental Therapeutics. 323: 599-605. PMID 17675585 DOI: 10.1124/Jpet.107.123042 |
0.647 |
|
| 2007 |
Wade-Galuska T, Winger G, Woods JH. A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys. Psychopharmacology. 194: 563-72. PMID 17628791 DOI: 10.1007/s00213-007-0858-0 |
0.358 |
|
| 2007 |
Zhang H, Shi YG, Woods JH, Watson SJ, Ko MC. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. European Journal of Pharmacology. 570: 89-96. PMID 17601558 DOI: 10.1016/j.ejphar.2007.05.045 |
0.443 |
|
| 2007 |
Collins GT, Newman AH, Grundt P, Rice KC, Husbands SM, Chauvignac C, Chen J, Wang S, Woods JH. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology. 193: 159-70. PMID 17393143 DOI: 10.1007/S00213-007-0766-3 |
0.622 |
|
| 2007 |
Galuska CM, Wade-Galuska T, Woods JH, Winger G. Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses. Behavioural Pharmacology. 18: 171-5. PMID 17351424 DOI: 10.1097/FBP.0b013e3280d48073 |
0.407 |
|
| 2007 |
Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, Woods JH. Cocaine esterase: interactions with cocaine and immune responses in mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 926-33. PMID 17114567 DOI: 10.1124/Jpet.106.114223 |
0.689 |
|
| 2007 |
Jutkiewicz EM, DenBesten N, Carroll FI, Woods JH. Depressant‐like effects of delta‐opioid receptor blockade in the forced swim test in rats The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A411-B |
0.625 |
|
| 2006 |
Galuska CM, Winger G, Hursh SR, Woods JH. Assessing unit-price related remifentanil choice in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 86: 181-95. PMID 17002226 DOI: 10.1901/jeab.2006.108.05 |
0.331 |
|
| 2006 |
Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, Woods JH. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Molecular Pharmacology. 70: 1885-91. PMID 16968810 DOI: 10.1124/Mol.106.025999 |
0.785 |
|
| 2006 |
Nieland NP, Moynihan HA, Carrington S, Broadbear J, Woods JH, Traynor JR, Husbands SM, Lewis JW. Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones. Journal of Medicinal Chemistry. 49: 5333-8. PMID 16913723 DOI: 10.1021/jm0604777 |
0.361 |
|
| 2006 |
Ko MC, Wei H, Woods JH, Kennedy RT. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies. The Journal of Pharmacology and Experimental Therapeutics. 318: 1257-64. PMID 16766718 DOI: 10.1124/Jpet.106.106120 |
0.345 |
|
| 2006 |
Wood SK, Verhoeven RE, Savit AZ, Rice KC, Fischbach PS, Woods JH. Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2580-90. PMID 16710322 DOI: 10.1038/Sj.Npp.1301085 |
0.625 |
|
| 2006 |
Winger G, Galuska CM, Hursh SR, Woods JH. Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 318: 223-9. PMID 16571623 DOI: 10.1124/jpet.105.100461 |
0.408 |
|
| 2006 |
Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. The Journal of Pharmacology and Experimental Therapeutics. 317: 1337-48. PMID 16537798 DOI: 10.1124/Jpet.105.095810 |
0.822 |
|
| 2006 |
Zhang H, Torregrossa MM, Jutkiewicz EM, Shi YG, Rice KC, Woods JH, Watson SJ, Ko MC. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects. The European Journal of Neuroscience. 23: 984-94. PMID 16519663 DOI: 10.1111/J.1460-9568.2006.04621.X |
0.781 |
|
| 2006 |
Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacology, Biochemistry, and Behavior. 83: 122-9. PMID 16460788 DOI: 10.1016/J.Pbb.2005.12.015 |
0.623 |
|
| 2006 |
Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. European Journal of Pharmacology. 531: 151-9. PMID 16442521 DOI: 10.1016/J.Ejphar.2005.12.002 |
0.8 |
|
| 2006 |
Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, Watson SJ, Woods JH. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Research. 1069: 172-81. PMID 16364263 DOI: 10.1016/J.Brainres.2005.11.005 |
0.772 |
|
| 2006 |
Ko MC, Divin MF, Lee H, Woods JH, Traynor JR. Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey. The Journal of Pharmacology and Experimental Therapeutics. 316: 772-9. PMID 16258020 DOI: 10.1124/Jpet.105.094409 |
0.389 |
|
| 2005 |
Fantegrossi WE, Kugle KM, Valdes LJ, Koreeda M, Woods JH. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse. Behavioural Pharmacology. 16: 627-33. PMID 16286814 DOI: 10.1097/00008877-200512000-00005 |
0.703 |
|
| 2005 |
Galuska CM, Woods JH. Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 84: 269-80. PMID 16262189 DOI: 10.1901/jeab.2005.99-04 |
0.433 |
|
| 2005 |
Torregrossa MM, Folk JE, Rice KC, Watson SJ, Woods JH. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology. 183: 31-40. PMID 16220339 DOI: 10.1007/S00213-005-0113-5 |
0.643 |
|
| 2005 |
Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology. 182: 588-96. PMID 16163520 DOI: 10.1007/S00213-005-0138-9 |
0.724 |
|
| 2005 |
Cook JB, Foster KL, Eiler WJ, McKay PF, Woods J, Harvey SC, Garcia M, Grey C, McCane S, Mason D, Cummings R, Li X, Cook JM, June HL. Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol. Alcoholism, Clinical and Experimental Research. 29: 1390-401. PMID 16131846 DOI: 10.1097/01.Alc.0000175073.94575.86 |
0.335 |
|
| 2005 |
Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 315: 414-22. PMID 16014751 DOI: 10.1124/Jpet.105.088831 |
0.718 |
|
| 2005 |
Fantegrossi WE, Kiessel CL, De la Garza R, Woods JH. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. Psychopharmacology. 181: 529-36. PMID 15983787 DOI: 10.1007/s00213-005-0005-8 |
0.623 |
|
| 2005 |
Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology. 181: 496-503. PMID 15983786 DOI: 10.1007/S00213-005-0009-4 |
0.631 |
|
| 2005 |
Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. The Journal of Pharmacology and Experimental Therapeutics. 314: 310-9. PMID 15833897 DOI: 10.1124/Jpet.105.085472 |
0.626 |
|
| 2005 |
Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, Woods JH, Lewis JW, Traynor JR. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. European Journal of Pharmacology. 509: 117-25. PMID 15733546 DOI: 10.1016/j.ejphar.2004.12.035 |
0.462 |
|
| 2005 |
Jutkiewicz EM, Wood SK, Houshyar H, Hsin LW, Rice KC, Woods JH. The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology. 180: 215-23. PMID 15696320 DOI: 10.1007/S00213-005-2164-Z |
0.791 |
|
| 2005 |
Fantegrossi WE, Ko MC, Woods JH, Richelson E. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 80: 341-9. PMID 15680187 DOI: 10.1016/j.pbb.2004.12.005 |
0.701 |
|
| 2005 |
Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug and Alcohol Dependence. 77: 161-8. PMID 15664717 DOI: 10.1016/J.Drugalcdep.2004.07.014 |
0.695 |
|
| 2005 |
Jutkiewicz EM, Walker NP, Folk JE, Rice KC, Portoghese PS, Woods JH, Traynor JR. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 312: 1314-20. PMID 15574687 DOI: 10.1124/Jpet.104.078741 |
0.69 |
|
| 2005 |
Broadbear JH, Winger G, Woods JH. Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology. 178: 83-91. PMID 15322724 DOI: 10.1007/s00213-004-1986-4 |
0.387 |
|
| 2004 |
Parrott AC, Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. MDMA and the loss of reinforcement in Fantegrossi et al (2004) (multiple letters) Neuropsychopharmacology. 29: 1940-1942. PMID 15383828 DOI: 10.1038/Sj.Npp.1300538 |
0.65 |
|
| 2004 |
Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. European Journal of Pharmacology. 499: 107-16. PMID 15363957 DOI: 10.1016/j.ejphar.2004.07.097 |
0.454 |
|
| 2004 |
Broadbear JH, Winger G, Woods JH. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology. 176: 398-406. PMID 15114434 DOI: 10.1007/s00213-004-1891-x |
0.494 |
|
| 2004 |
Williams KL, Broadbear JH, Woods JH. Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 28: 566-71. PMID 15100607 DOI: 10.1097/01.ALC.0000121655.48922.C4 |
0.322 |
|
| 2004 |
Fantegrossi WE, Woods JH, Winger G. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behavioural Pharmacology. 15: 149-57. PMID 15096915 DOI: 10.1097/00008877-200403000-00007 |
0.661 |
|
| 2004 |
Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Medicine Reviews. 8: 7-17. PMID 15062207 DOI: 10.1016/S1087-0792(03)00042-X |
0.311 |
|
| 2004 |
Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1270-81. PMID 15039771 DOI: 10.1038/Sj.Npp.1300442 |
0.743 |
|
| 2004 |
Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1112-21. PMID 14997174 DOI: 10.1038/Sj.Npp.1300410 |
0.389 |
|
| 2004 |
Fantegrossi WE, Kiessel CL, Leach PT, Van Martin C, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice. Psychopharmacology. 173: 270-7. PMID 14740148 DOI: 10.1007/S00213-003-1741-2 |
0.676 |
|
| 2004 |
Jutkiewicz EM, Eller EB, Folk JE, Rice KC, Traynor JR, Woods JH. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 309: 173-81. PMID 14722329 DOI: 10.1124/Jpet.103.061242 |
0.68 |
|
| 2004 |
Torregrossa MM, Isgor C, Folk JE, Rice KC, Watson SJ, Woods JH. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 649-59. PMID 14647482 DOI: 10.1038/Sj.Npp.1300345 |
0.655 |
|
| 2004 |
Chadman KK, Woods JH. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 308: 73-8. PMID 14566012 DOI: 10.1124/Jpet.103.057307 |
0.71 |
|
| 2004 |
Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004) Neuropsychopharmacology. 29: 1942-1942. DOI: 10.1038/Sj.Npp.1300539 |
0.65 |
|
| 2003 |
Jutkiewicz EM, Rice KC, Woods JH, Winsauer PJ. Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats. Behavioural Pharmacology. 14: 509-16. PMID 14557718 DOI: 10.1097/00008877-200311000-00003 |
0.674 |
|
| 2003 |
Lee H, Naughton NN, Woods JH, Ko MC. Characterization of scratching responses in rats following centrally administered morphine or bombesin. Behavioural Pharmacology. 14: 501-8. PMID 14557717 DOI: 10.1097/01.fbp.0000095082.80017.0f |
0.448 |
|
| 2003 |
Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Research. 982: 38-44. PMID 12915238 DOI: 10.1016/S0006-8993(03)02938-X |
0.825 |
|
| 2003 |
Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2000-9. PMID 12902992 DOI: 10.1038/Sj.Npp.1300251 |
0.72 |
|
| 2003 |
Greiner E, Spetea M, Krassnig R, Schüllner F, Aceto M, Harris LS, Traynor JR, Woods JH, Coop A, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships. Journal of Medicinal Chemistry. 46: 1758-63. PMID 12699394 DOI: 10.1021/jm021118o |
0.397 |
|
| 2003 |
Williams KL, Ko MC, Rice KC, Woods JH. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology. 28: 513-28. PMID 12689609 DOI: 10.1016/S0306-4530(02)00037-9 |
0.467 |
|
| 2003 |
Ko MC, Lee H, Harrison C, Clark MJ, Song HF, Naughton NN, Woods JH, Traynor JR. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. The Journal of Pharmacology and Experimental Therapeutics. 306: 179-86. PMID 12676881 DOI: 10.1124/jpet.103.050625 |
0.405 |
|
| 2003 |
Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 305: 173-9. PMID 12649366 DOI: 10.1124/Jpet.102.044909 |
0.469 |
|
| 2003 |
Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology. 166: 202-11. PMID 12563544 DOI: 10.1007/S00213-002-1261-5 |
0.644 |
|
| 2003 |
Flory GS, Woods JH. The ascending limb of the cocaine dose-response curve for reinforcing effect in rhesus monkeys. Psychopharmacology. 166: 91-4. PMID 12529810 DOI: 10.1007/S00213-002-1336-3 |
0.825 |
|
| 2003 |
May EL, Coop A, Woods JH, Aceto MD, Bowman ER, Harris LS, Traynor JR. N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones. Bioorganic & Medicinal Chemistry. 11: 31-3. PMID 12467704 DOI: 10.1016/S0968-0896(02)00435-2 |
0.362 |
|
| 2002 |
Broadbear JH, Winger G, Rice KC, Woods JH. Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys. Psychopharmacology. 164: 268-76. PMID 12424550 DOI: 10.1007/S00213-002-1187-Y |
0.412 |
|
| 2002 |
Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Behavioral effects of delta-opioid receptor agonists: potential antidepressants? Japanese Journal of Pharmacology. 90: 1-6. PMID 12396021 DOI: 10.1254/Jjp.90.1 |
0.825 |
|
| 2002 |
Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 723-9. PMID 12388657 DOI: 10.1124/Jpet.102.036525 |
0.802 |
|
| 2002 |
Woods JH, France CP. Determinants of the behavioral effects of opioids and their antagonists: contributions of the Laboratory of Psychobiology. Psychopharmacology. 163: 406-11. PMID 12373441 DOI: 10.1007/s00213-002-1212-1 |
0.561 |
|
| 2002 |
Woods JH, Winger GD. Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys. Psychopharmacology. 163: 345-51. PMID 12373435 DOI: 10.1007/s00213-002-1201-4 |
0.354 |
|
| 2002 |
Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology. 164: 42-8. PMID 12373418 DOI: 10.1007/S00213-002-1179-Y |
0.824 |
|
| 2002 |
Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology. 161: 356-64. PMID 12073162 DOI: 10.1007/S00213-002-1021-6 |
0.72 |
|
| 2002 |
Koetzner L, Woods JH. Characterization of equine butyrylcholinesterase disposition in the mouse. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 724-30. PMID 12019201 DOI: 10.1124/Dmd.30.6.724 |
0.749 |
|
| 2002 |
Koetzner L, Woods JH. Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 716-23. PMID 12019200 DOI: 10.1124/Dmd.30.6.716 |
0.761 |
|
| 2002 |
Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 744-55. PMID 12007745 DOI: 10.1016/S0893-133X(01)00413-4 |
0.824 |
|
| 2002 |
Ko MC, Terner J, Hursh S, Woods JH, Winger G. Relative reinforcing effects of three opioids with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 301: 698-704. PMID 11961075 DOI: 10.1124/jpet.301.2.698 |
0.317 |
|
| 2002 |
Ko MC, Naughton NN, Traynor JR, Song MS, Woods JH, Rice KC, McKnight AT. Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors. British Journal of Pharmacology. 135: 943-50. PMID 11861322 DOI: 10.1038/Sj.Bjp.0704535 |
0.453 |
|
| 2002 |
Koetzner L, Sumpter TL, Woods JH. Tetrabenazine fails to antagonize a behavioral effect of cocaine in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 71: 1-5. PMID 11812502 DOI: 10.1016/S0091-3057(01)00532-9 |
0.772 |
|
| 2002 |
Alt A, Clark MJ, Woods JH, Traynor JR. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. British Journal of Pharmacology. 135: 217-25. PMID 11786497 DOI: 10.1038/Sj.Bjp.0704430 |
0.719 |
|
| 2001 |
Anderson KG, Winger G, Woods J, Woolverton WL. Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys. Drug and Alcohol Dependence. 65: 45-53. PMID 11714589 DOI: 10.1016/S0376-8716(01)00143-0 |
0.489 |
|
| 2001 |
Houshyar H, Galigniana MD, Pratt WB, Woods JH. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. Journal of Neuroendocrinology. 13: 875-86. PMID 11679056 DOI: 10.1046/j.1365-2826.2001.00714.x |
0.754 |
|
| 2001 |
Houshyar H, Cooper ZD, Woods JH. Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. Journal of Neuroendocrinology. 13: 862-74. PMID 11679055 DOI: 10.1046/J.1365-2826.2001.00713.X |
0.807 |
|
| 2001 |
Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH. GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 298: 1049-59. PMID 11504802 |
0.34 |
|
| 2001 |
Briscoe RJ, Jeanville PM, Cabrera C, Baird TJ, Woods JH, Landry DW. A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. International Immunopharmacology. 1: 1189-98. PMID 11407313 DOI: 10.1016/S1567-5769(01)00054-6 |
0.418 |
|
| 2001 |
Gerak LR, Woolverton WL, Nader MA, Patrick GA, Harris LS, Winger G, Woods JH, France CP. Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats. Drug and Alcohol Dependence. 63: 39-49. PMID 11297830 DOI: 10.1016/S0376-8716(00)00189-7 |
0.736 |
|
| 2001 |
Winger G, Woods JH. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug and Alcohol Dependence. 62: 181-9. PMID 11295322 DOI: 10.1016/S0376-8716(00)00166-6 |
0.529 |
|
| 2001 |
Koetzner L, Deng S, Sumpter TL, Weisslitz M, Abner RT, Landry DW, Woods JH. Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 296: 789-96. PMID 11181908 |
0.737 |
|
| 2000 |
May EL, Jacobson AE, Mattson MV, Traynor JR, Woods JH, Harris LS, Bowman ER, Aceto MD. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues. Journal of Medicinal Chemistry. 43: 5030-6. PMID 11150174 DOI: 10.1021/jm000317 |
0.338 |
|
| 2000 |
Baird TJ, Deng SX, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 295: 1127-34. PMID 11082449 |
0.363 |
|
| 2000 |
Coop A, Jacobson AE, Aceto MD, Harris LS, Traynor JR, Woods JH, Rice KC. N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole. Bioorganic & Medicinal Chemistry Letters. 10: 2449-51. PMID 11078198 DOI: 10.1016/S0960-894X(00)00479-0 |
0.39 |
|
| 2000 |
Briscoe RJ, Cabrera CL, Baird TJ, Rice KC, Woods JH. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Research. 881: 204-7. PMID 11036160 DOI: 10.1016/S0006-8993(00)02742-6 |
0.378 |
|
| 2000 |
McFadyen IJ, Houshyar H, Liu-Chen LY, Woods JH, Traynor JR. The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore. Molecular Pharmacology. 58: 669-76. PMID 10999935 DOI: 10.1124/Mol.58.4.669 |
0.786 |
|
| 2000 |
Derrick I, Neilan CL, Andes J, Husbands SM, Woods JH, Traynor JR, Lewis JW. 3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group. Journal of Medicinal Chemistry. 43: 3348-50. PMID 10966754 DOI: 10.1021/Jm0009641 |
0.401 |
|
| 2000 |
Broom DC, Guo L, Coop A, Husbands SM, Lewis JW, Woods JH, Traynor JR. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 294: 1195-200. PMID 10945877 |
0.802 |
|
| 2000 |
Zubieta J, Greenwald MK, Lombardi U, Woods JH, Kilbourn MR, Jewett DM, Koeppe RA, Schuster CR, Johanson CE. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 326-34. PMID 10942856 DOI: 10.1016/S0893-133X(00)00110-X |
0.733 |
|
| 2000 |
Ko MC, Willmont KJ, Burritt A, Hruby VJ, Woods JH. Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys. European Journal of Pharmacology. 402: 69-76. PMID 10940359 DOI: 10.1016/S0014-2999(00)00503-3 |
0.46 |
|
| 2000 |
Briscoe RJ, Winger G, Lewis JW, Woods JH. Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys. Psychopharmacology. 148: 393-9. PMID 10928312 DOI: 10.1007/S002130050068 |
0.512 |
|
| 2000 |
Kishioka S, Paronis CA, Woods JH. Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys. European Journal of Pharmacology. 398: 121-30. PMID 10856456 DOI: 10.1016/S0014-2999(00)00279-X |
0.388 |
|
| 2000 |
Kishioka S, Ko MC, Woods JH. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys. European Journal of Pharmacology. 397: 85-92. PMID 10844102 DOI: 10.1016/S0014-2999(00)00248-X |
0.471 |
|
| 2000 |
Remmers AE, Clark MJ, Alt A, Medzihradsky F, Woods JH, Traynor JR. Activation of G protein by opioid receptors: role of receptor number and G-protein concentration. European Journal of Pharmacology. 396: 67-75. PMID 10822058 DOI: 10.1016/S0014-2999(00)00212-0 |
0.721 |
|
| 2000 |
Houshyar H, Mc Fadyen IJ, Woods JH, Traynor JR. Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor. European Journal of Pharmacology. 395: 121-8. PMID 10794817 DOI: 10.1016/S0014-2999(00)00176-X |
0.801 |
|
| 2000 |
Kishioka S, Paronis CA, Lewis JW, Woods JH. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys. European Journal of Pharmacology. 391: 289-97. PMID 10729371 DOI: 10.1016/S0014-2999(00)00039-X |
0.495 |
|
| 2000 |
Ko MC, Tuchman JE, Johnson MD, Wiesenauer K, Woods JH. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats. Psychopharmacology. 148: 180-5. PMID 10663433 DOI: 10.1007/S002130050040 |
0.47 |
|
| 2000 |
Derrick I, Husbands SM, Broadbear J, Traynor JR, Woods JH, Lewis JW. Cinnamoyl derivatives of 7a-amino- and 7a-(aminomethyl)- N-(cyclopropylmethyl)-6,14-endo-ethanotetrahydronororipavines are high-potency opioid antagonists Helvetica Chimica Acta. 83: 3122-3130. DOI: 10.1002/1522-2675(20001220)83:12<3122::Aid-Hlca3122>3.0.Co;2-2 |
0.349 |
|
| 1999 |
Patrick CA, Holden Ko MC, Woods JH. Comparison of Antinociceptive Effects Induced by Kappa Opioid Agonists in Male and Female Mice. Analgesia (Elmsford, N.Y.). 4: 397-404. PMID 21687823 |
0.337 |
|
| 1999 |
Vivian JA, Sumpter TL, Woods JH. Further characterization of the quinine taste discrimination stimulus in rhesus monkeys: effects of inter-trial interval, number and distribution of test stimuli. Behavioural Pharmacology. 10: 313-8. PMID 10780245 DOI: 10.1097/00008877-199905000-00007 |
0.301 |
|
| 1999 |
Vivian JA, Liang YJ, Higley JD, Linnoila M, Woods JH. Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys. Psychopharmacology. 147: 113-24. PMID 10591878 DOI: 10.1007/S002130051151 |
0.369 |
|
| 1999 |
Broadbear JH, Winger G, Woods JH. Glucocorticoid-reinforced responding in the rhesus monkey. Psychopharmacology. 147: 46-55. PMID 10591868 DOI: 10.1007/s002130051141 |
0.408 |
|
| 1999 |
Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 291: 1113-20. PMID 10565831 |
0.356 |
|
| 1999 |
Neilan CL, Akil H, Woods JH, Traynor JR. Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists. British Journal of Pharmacology. 128: 556-62. PMID 10516632 DOI: 10.1038/sj.bjp.0702816 |
0.421 |
|
| 1999 |
Lee KO, Akil H, Woods JH, Traynor JR. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. European Journal of Pharmacology. 378: 323-30. PMID 10493109 DOI: 10.1016/S0014-2999(99)00460-4 |
0.429 |
|
| 1999 |
Rowlett JK, Winger G, Carter RB, Wood PL, Woods JH, Woolverton WL. Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology. 145: 205-12. PMID 10463322 DOI: 10.1007/S002130051050 |
0.422 |
|
| 1999 |
Broadbear JH, Winger G, Woods JH. Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response. The Journal of Pharmacology and Experimental Therapeutics. 290: 1347-55. PMID 10454513 |
0.346 |
|
| 1999 |
Williams KL, Pakarinen ED, Woods JH. Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects. Psychopharmacology. 144: 316-22. PMID 10435403 DOI: 10.1007/s002130051013 |
0.455 |
|
| 1999 |
Broadbear JH, Winger G, Cicero TJ, Woods JH. Effects of response contingent and noncontingent cocaine injection on hypothalamic-pituitary-adrenal activity in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 290: 393-402. PMID 10381805 |
0.34 |
|
| 1999 |
Vivian JA, DeYoung MB, Sumpter TL, Traynor JR, Lewis JW, Woods JH. kappa-Opioid receptor effects of butorphanol in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 290: 259-65. PMID 10381785 |
0.378 |
|
| 1999 |
Ko MC, Woods JH. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. Psychopharmacology. 143: 322-6. PMID 10353438 DOI: 10.1007/s002130050955 |
0.384 |
|
| 1999 |
Broadbear JH, Winger G, Cicero TJ, Woods JH. Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 289: 1641-7. PMID 10336563 |
0.329 |
|
| 1999 |
Butelman ER, Vivian JA, Yu J, Kreek MJ, Woods JH. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys. Psychopharmacology. 143: 190-6. PMID 10326782 DOI: 10.1007/S002130050935 |
0.45 |
|
| 1999 |
Williams KL, Woods JH. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 23: 708-15. PMID 10235307 DOI: 10.1097/00000374-199904001-00018 |
0.39 |
|
| 1999 |
Woolverton WL, Rowlett JK, Winger G, Woods JH, Gerak LR, France CP. Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug and Alcohol Dependence. 54: 137-43. PMID 10217553 DOI: 10.1016/S0376-8716(98)00153-7 |
0.738 |
|
| 1999 |
Ko MC, Butelman ER, Woods JH. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 289: 378-85. PMID 10087027 |
0.373 |
|
| 1999 |
Naughton NN, Ko MC, Johnson MD, Willmont KJ, Woods JH. Characterization of Morphine Induced Pruritus and Antinociception in an Experimental Monkey Model Anesthesiology. 90. DOI: 10.1097/00000542-199904001-00020 |
0.377 |
|
| 1998 |
Williams KL, Woods JH. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcoholism, Clinical and Experimental Research. 22: 1634-9. PMID 9835275 DOI: 10.1111/J.1530-0277.1998.Tb03960.X |
0.416 |
|
| 1998 |
Williams KL, Winger G, Pakarinen ED, Woods JH. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology. 139: 53-61. PMID 9768542 DOI: 10.1007/S002130050689 |
0.318 |
|
| 1998 |
Husbands SM, Sadd J, Broadbear JH, Woods JH, Martin J, Traynor JR, Aceto MD, Bowman ER, Harris LS, Lewis JW. 3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy. Journal of Medicinal Chemistry. 41: 3493-8. PMID 9719602 DOI: 10.1021/Jm9810248 |
0.462 |
|
| 1998 |
Lieberman PB, Woods JH, Young EA. The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist. European Journal of Pharmacology. 352: 73-9. PMID 9718270 DOI: 10.1016/S0014-2999(98)00341-0 |
0.433 |
|
| 1998 |
Mets B, Winger G, Cabrera C, Seo S, Jamdar S, Yang G, Zhao K, Briscoe RJ, Almonte R, Woods JH, Landry DW. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proceedings of the National Academy of Sciences of the United States of America. 95: 10176-81. PMID 9707620 DOI: 10.1073/Pnas.95.17.10176 |
0.419 |
|
| 1998 |
Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A. The Journal of Pharmacology and Experimental Therapeutics. 286: 697-703. PMID 9694923 |
0.317 |
|
| 1998 |
France CP, Gerak LR, Rowlett JK, Woolverton WL, Winger G, Woods JH. Progress report from the testing program for stimulant and depressant drugs (1996). Nida Research Monograph. 178: 429-39. PMID 9686406 |
0.645 |
|
| 1998 |
Alt A, Mansour A, Akil H, Medzihradsky F, Traynor JR, Woods JH. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. The Journal of Pharmacology and Experimental Therapeutics. 286: 282-8. PMID 9655870 |
0.307 |
|
| 1998 |
Ko MC, Butelman ER, Woods JH. The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 286: 150-6. PMID 9655854 |
0.375 |
|
| 1998 |
Butelman ER, Ko MC, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, Woods JH. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. The Journal of Pharmacology and Experimental Therapeutics. 285: 595-601. PMID 9580603 |
0.332 |
|
| 1998 |
Ko MC, Butelman ER, Traynor JR, Woods JH. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 285: 518-26. PMID 9580592 |
0.351 |
|
| 1998 |
Elmer GI, Pieper JO, Negus SS, Woods JH. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain. 75: 129-40. PMID 9539682 DOI: 10.1016/S0304-3959(97)00215-7 |
0.34 |
|
| 1997 |
Paronis CA, Woods JH. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats. European Journal of Pharmacology. 337: 27-34. PMID 9389377 DOI: 10.1016/S0014-2999(97)01296-X |
0.445 |
|
| 1997 |
Paronis CA, Woods JH. Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 282: 348-54. PMID 9223573 |
0.316 |
|
| 1997 |
Woods JH, Winger G. Abuse liability of flunitrazepam. Journal of Clinical Psychopharmacology. 17: 1S-57S. PMID 9169981 DOI: 10.1097/00004714-199706001-00001 |
0.41 |
|
| 1997 |
Zernig G, Lewis JW, Woods JH. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception. Psychopharmacology. 129: 233-42. PMID 9084061 DOI: 10.1007/S002130050185 |
0.49 |
|
| 1996 |
Winger G, Woods JH. Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys. Behavioural Pharmacology. 7: 155-159. PMID 11224407 |
0.389 |
|
| 1996 |
Derrick I, Lewis JW, Moynihan HA, Broadbear J, Woods JH. Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of beta-naltrexamine. The Journal of Pharmacy and Pharmacology. 48: 192-6. PMID 8935170 DOI: 10.1111/j.2042-7158.1996.tb07121.x |
0.381 |
|
| 1996 |
Butelman ER, Lewis JW, Woods JH. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 279: 934-8. PMID 8930202 |
0.367 |
|
| 1996 |
Jewett DC, Mosberg HI, Woods JH. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons. Psychopharmacology. 127: 225-30. PMID 8912400 DOI: 10.1007/Bf02246130 |
0.471 |
|
| 1996 |
Acteo MD, Bowman E, Butelman E, Englis JA, Harrish L, Jacobson AE, Mattson MV, Medzihradsky F, Patrick G, Rowlett JK, Smith CB, Winger G, Woods JH, Woolverton WL. Zipeprol: preclinical assessment of abuse potential. Drug and Alcohol Dependence. 42: 93-104. PMID 8889408 DOI: 10.1016/0376-8716(96)01267-7 |
0.496 |
|
| 1996 |
Butelman ER, Negus SS, Lewis JW, Woods JH. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys. Psychopharmacology. 123: 320-4. PMID 8867870 DOI: 10.1007/Bf02246641 |
0.492 |
|
| 1996 |
Zernig G, Issaevitch T, Woods JH. Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches. Journal of Pharmacological and Toxicological Methods. 35: 223-37. PMID 8823669 DOI: 10.1016/1056-8719(96)00053-6 |
0.354 |
|
| 1996 |
Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. The Journal of Pharmacology and Experimental Therapeutics. 278: 1121-7. PMID 8819494 |
0.324 |
|
| 1996 |
Jewett DC, Butelman ER, Woods JH. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Research. 715: 25-31. PMID 8739619 DOI: 10.1016/0006-8993(95)01328-8 |
0.337 |
|
| 1996 |
Winger G, Woods JH, Hursh SR. Behavior maintained by alfentanil or nalbuphine in rhesus monkeys: Fixed-ratio and time-out changes to establish demand curves and relative reinforcing effectiveness Experimental and Clinical Psychopharmacology. 4: 131-140. DOI: 10.1037/1064-1297.4.2.131 |
0.314 |
|
| 1996 |
Derrick I, Moynihan HA, Broadbear J, Woods JH, Lewis JW. 6N-Cinnamoyl-β-naltrexamine and its p-nitro derivative. High efficacy κ-opioid agonists with weak antagonist actions Bioorganic & Medicinal Chemistry Letters. 6: 167-172. DOI: 10.1016/0960-894X(95)00583-F |
0.384 |
|
| 1996 |
Broadbear JH, Lewis JW, Woods JH. Alternative pharmacotherapies in the treatment of opioid addiction European Neuropsychopharmacology. 6: 120. DOI: 10.1016/0924-977X(96)87855-2 |
0.401 |
|
| 1995 |
Jewett DC, Woods JH. Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons. Behavioural Pharmacology. 6: 815-820. PMID 11224385 |
0.384 |
|
| 1995 |
Woods JH, Lewis JW, Winger G, Butelman E, Broadbear J, Zernig G. Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse. Nida Research Monograph. 147: 195-219. PMID 8742788 |
0.334 |
|
| 1995 |
Butelman ER, Winger G, Zernig G, Woods JH. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 272: 845-53. PMID 7853203 |
0.34 |
|
| 1995 |
Pakarinen ED, Woods JH, Moerschbaecher JM. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist. The Journal of Pharmacology and Experimental Therapeutics. 272: 552-9. PMID 7853168 |
0.374 |
|
| 1995 |
Walker EA, Zernig G, Woods JH. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. The Journal of Pharmacology and Experimental Therapeutics. 273: 1345-52. PMID 7791107 |
0.685 |
|
| 1995 |
Negus SS, Butelman ER, Gatch MB, Woods JH. Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 274: 805-14. PMID 7636744 |
0.354 |
|
| 1995 |
Woods JH, Winger G. Current benzodiazepine issues. Psychopharmacology. 118: 107-15; discussion 1. PMID 7617794 DOI: 10.1007/Bf02245824 |
0.328 |
|
| 1995 |
France CP, Gerak LR, Flynn D, Winger GD, Medzihradsky F, Bagley JR, Brockunier LL, Woods JH. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 274: 17-28. PMID 7616395 |
0.753 |
|
| 1995 |
Baron SP, Woods JH. Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology. 118: 42-51. PMID 7597121 DOI: 10.1007/Bf02245248 |
0.365 |
|
| 1995 |
Butelman ER, France CP, Woods JH. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 275: 374-80. PMID 7562573 |
0.594 |
|
| 1995 |
Butelman ER, Negus SS, Gatch MB, Chang KJ, Woods JH. BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. European Journal of Pharmacology. 277: 285-7. PMID 7493622 DOI: 10.1016/0014-2999(95)00134-7 |
0.484 |
|
| 1995 |
Zernig G, Issaevitch T, Broadbear JH, Burke TF, Lewis JW, Brine GA, Woods JH. Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding. Life Sciences. 57: 2113-25. PMID 7475964 DOI: 10.1016/0024-3205(95)02204-V |
0.456 |
|
| 1995 |
Woods JH, Winger G, Pakarinen E, Aspen J. Reinforcing Effects Of Nmda Antagonists In Rhesus Monkeys Behavioural Pharmacology. 6. DOI: 10.1097/00008877-199508000-00090 |
0.328 |
|
| 1995 |
Zernig G, Broadbear J, Lewis JW, Brine GA, Woods JH. Opioid Agonist Effects on Mouse Writhing After Irreversible Mu Receptor Blockade With Clocinnamox Experimental and Clinical Psychopharmacology. 3: 323-329. DOI: 10.1037/1064-1297.3.4.323 |
0.444 |
|
| 1994 |
Takasuna M, Negus SS, DeCosta BR, Woods JH. Opioid pharmacology of the antinociceptive effects of loperamide in mice. Behavioural Pharmacology. 5: 189-195. PMID 11224267 DOI: 10.1097/00008877-199404000-00010 |
0.492 |
|
| 1994 |
Woods JH, France CP, Medzihradsky F, Smith CB, Winger GD. Evaluation of new compounds for opioid activity annual report (1993). Nida Research Monograph. 140: 196-247. PMID 8722466 |
0.518 |
|
| 1994 |
France CP, Medzihradsky F, Woods JH. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities. The Journal of Pharmacology and Experimental Therapeutics. 268: 47-58. PMID 8301589 |
0.57 |
|
| 1994 |
Zernig G, Butelman ER, Lewis JW, Walker EA, Woods JH. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. The Journal of Pharmacology and Experimental Therapeutics. 269: 57-65. PMID 8169852 |
0.694 |
|
| 1994 |
Gerak LR, Butelman ER, Woods JH, France CP. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 271: 993-9. PMID 7965822 |
0.757 |
|
| 1994 |
Burke TF, Woods JH, Lewis JW, Medzihradsky F. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. The Journal of Pharmacology and Experimental Therapeutics. 271: 715-21. PMID 7965787 |
0.354 |
|
| 1994 |
Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 270: 1025-34. PMID 7932149 |
0.386 |
|
| 1994 |
Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology. 115: 311-9. PMID 7871070 DOI: 10.1007/Bf02245071 |
0.482 |
|
| 1994 |
Zernig G, Burke T, Lewis J, Woods J. Clocinnamox blocks only mu receptors irreversibly: Binding evidence Regulatory Peptides. 54: 343-344. DOI: 10.1016/0167-0115(94)90529-0 |
0.331 |
|
| 1994 |
Zernig G, Butelman ER, Lewis J, Woods JH. In vivo determination of μ opioid receptor reserve and turnover in rhesus monkeys after irreversible blockade with clocinnamox Regulatory Peptides. 53: S59-S60. DOI: 10.1016/0167-0115(94)90240-2 |
0.453 |
|
| 1994 |
Woods JH. New pharmacotherapies for heroin addiction Pharmacology, Biochemistry and Behavior. 48: 825. DOI: 10.1016/0091-3057(94)90361-1 |
0.301 |
|
| 1993 |
France CP, Woods JH. U-50, 488, saline and naltrexone discrimination in U-50, 488-treated pigeons. Behavioural Pharmacology. 4: 509-516. PMID 11224218 |
0.593 |
|
| 1993 |
Baron SP, Woods JH. Effects of phencyclidine and dizocilpine on NMDA-, kainate-, and water deprivation-induced drinking in pigeons. Behavioural Pharmacology. 4: 257-261. PMID 11224193 DOI: 10.1097/00008877-199306000-00008 |
0.315 |
|
| 1993 |
Baron SP, Butelman ER, Woods JH. Discriminative stimulus effects of NMDA in pigeons and monkeys. Behavioural Pharmacology. 4: 115-123. PMID 11224178 DOI: 10.1097/00008877-199304000-00004 |
0.334 |
|
| 1993 |
Butelman ER, Baron SP, Woods JH. Ethanol effects in pigeons trained to discriminate MK-801, PCP or CGS-19755. Behavioural Pharmacology. 4: 57-60. PMID 11224171 DOI: 10.1097/00008877-199302000-00006 |
0.329 |
|
| 1993 |
Woods JH, France CP, Medzihradsky F, Smith CB, Winger GD. Evaluation of new compounds for opioid activity, 1992. Nida Research Monograph. 132: 517-78. PMID 8393529 |
0.521 |
|
| 1993 |
Negus SS, Butelman ER, Al Y, Woods JH. Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 266: 1355-63. PMID 8371142 |
0.37 |
|
| 1993 |
Skjoldager P, Winger G, Woods JH. Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug and Alcohol Dependence. 33: 31-9. PMID 8370338 DOI: 10.1016/0376-8716(93)90031-K |
0.441 |
|
| 1993 |
Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 267: 1269-76. PMID 8263790 |
0.394 |
|
| 1993 |
Negus SS, Burke TF, Medzihradsky F, Woods JH. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. The Journal of Pharmacology and Experimental Therapeutics. 267: 896-903. PMID 8246165 |
0.375 |
|
| 1993 |
Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. The Journal of Pharmacology and Experimental Therapeutics. 267: 888-95. PMID 8246164 |
0.341 |
|
| 1993 |
Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors. The Journal of Pharmacology and Experimental Therapeutics. 267: 866-74. PMID 8246161 |
0.381 |
|
| 1993 |
Butelman ER, Woods JH. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 264: 762-9. PMID 8094751 |
0.358 |
|
| 1993 |
Butelman ER, France CP, Woods JH. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 264: 145-51. PMID 8093721 |
0.561 |
|
| 1993 |
Walker EA, Butelman ER, DeCosta BR, Woods JH. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. The Journal of Pharmacology and Experimental Therapeutics. 267: 280-6. PMID 7901396 |
0.694 |
|
| 1992 |
France CP, Woods JH. Naloxone benzylhydrazone is a µ-selective opioid antagonist without kappa agonist effects in rhesus monkeys. Behavioural Pharmacology. 3: 133-141. PMID 11224111 |
0.616 |
|
| 1992 |
Winger G, Skjoldager P, Woods JH. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 261: 311-7. PMID 1560376 |
0.423 |
|
| 1992 |
Woods JH, Winger G, France CP. Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability. Trends in Pharmacological Sciences. 13: 282-6. PMID 1509522 DOI: 10.1016/0165-6147(92)90086-L |
0.621 |
|
| 1992 |
Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP. Evaluation of new compounds for opioid activity (1991). Nida Research Monograph. 119: 559-603. PMID 1435986 |
0.521 |
|
| 1992 |
Lu Y, France CP, Woods JH. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists. The Journal of Pharmacology and Experimental Therapeutics. 263: 499-504. PMID 1432686 |
0.504 |
|
| 1992 |
Woods JH, France CP, Winger GD. Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse. Nida Research Monograph. 121: 12-27. PMID 1406907 |
0.489 |
|
| 1992 |
France CP, Winger G, Seggel MR, Rice KC, Woods JH. Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys. Psychopharmacology. 109: 291-8. PMID 1365629 DOI: 10.1007/Bf02245876 |
0.616 |
|
| 1992 |
Bertalmio AJ, Woods JH. Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone. Psychopharmacology. 106: 189-94. PMID 1347952 DOI: 10.1007/Bf02801971 |
0.448 |
|
| 1992 |
Winger G, France CP, Woods JH, Smith CB, Medzihradsky F, Iorio MA. Opioid and non-opioid effects of novel butyrophenone analogues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 177-87. PMID 1326980 |
0.607 |
|
| 1992 |
Comer SD, Burke TF, Lewis JW, Woods JH. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist. The Journal of Pharmacology and Experimental Therapeutics. 262: 1051-6. PMID 1326622 |
0.366 |
|
| 1992 |
Bertalmio AJ, Medzihradsky F, Winger G, Woods JH. Differential influence of N-dealkylation on the stimulus properties of some opioid agonists. The Journal of Pharmacology and Experimental Therapeutics. 261: 278-84. PMID 1313871 |
0.315 |
|
| 1991 |
Butelman ER, France CP, Woods JH. The discriminative stimulus effects of MK-801 in pigeons. Behavioural Pharmacology. 2: 79-86. PMID 11224051 |
0.542 |
|
| 1991 |
France CP, Moerschbaecher JM, Woods JH. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination. The Journal of Pharmacology and Experimental Therapeutics. 257: 727-34. PMID 2033515 |
0.545 |
|
| 1991 |
Nader MA, Winger G, Woods JH, Woolverton WL. Discriminative and reinforcing effects of brotizolam in rhesus monkeys. Psychopharmacology. 103: 166-71. PMID 2027918 DOI: 10.1007/Bf02244198 |
0.405 |
|
| 1991 |
Skjoldager P, Winger G, Woods JH. Analysis of fixed-ratio behavior maintained by drug reinforcers. Journal of the Experimental Analysis of Behavior. 56: 331-43. PMID 1955820 DOI: 10.1901/jeab.1991.56-331 |
0.396 |
|
| 1991 |
Walker EA, Yamamoto T, Hollingsworth PJ, Smith CB, Woods JH. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 259: 772-82. PMID 1941625 |
0.572 |
|
| 1991 |
Yamamoto T, Walker EA, Woods JH. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. The Journal of Pharmacology and Experimental Therapeutics. 258: 999-1007. PMID 1890629 |
0.597 |
|
| 1991 |
France CP, Winger G, Medzihradsky F, Seggel MR, Rice KC, Woods JH. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects. The Journal of Pharmacology and Experimental Therapeutics. 258: 502-10. PMID 1650830 |
0.623 |
|
| 1991 |
Comer SD, France CP, Woods JH. Training dose: influences in opioid drug discrimination. Nida Research Monograph. 145-61. PMID 1369665 DOI: 10.1037/E496182006-010 |
0.539 |
|
| 1990 |
France CP, Woods JH. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. The Journal of Pharmacology and Experimental Therapeutics. 254: 626-32. PMID 2384889 |
0.604 |
|
| 1990 |
Thurkauf A, de Costa B, Mattson MV, France CP, Price MT, Olney JW, Woods JH, Jacobson AE, Rice KC. Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines. Journal of Medicinal Chemistry. 33: 2211-5. PMID 2374147 DOI: 10.1021/Jm00170A027 |
0.532 |
|
| 1990 |
France CP, Lu Y, Woods JH. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 255: 1271-7. PMID 2262905 |
0.484 |
|
| 1990 |
France CP, Winger GD, Woods JH. Analgesic, anesthetic, and respiratory effects of the competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys. Brain Research. 526: 355-8. PMID 2257491 DOI: 10.1016/0006-8993(90)91247-E |
0.57 |
|
| 1990 |
France CP, de Costa BR, Jacobson AE, Rice KC, Woods JH. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. The Journal of Pharmacology and Experimental Therapeutics. 252: 600-4. PMID 2156055 |
0.618 |
|
| 1990 |
France CP, Woods JH. Respiratory effects of receptor-selective opioids in rhesus monkeys. Progress in Clinical and Biological Research. 328: 295-8. PMID 2154784 |
0.572 |
|
| 1990 |
Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP. Evaluation of new compounds for opioid activity (1990). Nida Research Monograph. 105: 682-724. PMID 1876152 |
0.521 |
|
| 1990 |
Walker EA, Woods JH. Apparent affinity estimates for nalbuphine, an opioid partial agonist, in a rhesus monkey tail-withdrawal procedure European Journal of Pharmacology. 183: 2304. DOI: 10.1016/0014-2999(90)93857-M |
0.683 |
|
| 1989 |
Winger GD, Palmer RK, Woods JH. Drug-reinforced responding: rapid determination of dose-response functions Drug and Alcohol Dependence. 24: 135-142. PMID 2676442 DOI: 10.1016/0376-8716(89)90076-8 |
0.446 |
|
| 1989 |
France CP, Woods JH, Ornstein P. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. European Journal of Pharmacology. 159: 133-9. PMID 2651134 DOI: 10.1016/0014-2999(89)90697-3 |
0.573 |
|
| 1989 |
Rothman RB, France CP, Bykov V, De Costa BR, Jacobson AE, Woods JH, Rice KC. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes. European Journal of Pharmacology. 167: 345-53. PMID 2553442 DOI: 10.1016/0014-2999(89)90443-3 |
0.541 |
|
| 1989 |
Koek W, Woods JH. Partial generalization in pigeons trained to discriminate morphine from saline: Applications of receptor theory Drug Development Research. 16: 169-181. DOI: 10.1002/Ddr.430160211 |
0.443 |
|
| 1989 |
Woods JH, Winger G, Katz JL. Abuse of Benzodiazepines-Reply Jama. 261: 2956-2957. DOI: 10.1001/Jama.1989.03420200046029 |
0.307 |
|
| 1988 |
Koek W, Woods JH. 2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. Neuropharmacology. 27: 771-775. PMID 2843787 DOI: 10.1016/0028-3908(88)90089-5 |
0.32 |
|
| 1988 |
Woods JH, Bertalmio AJ, Young AM, Essman WD, Winger G. Receptor mechanisms of opioid drug discrimination. Psychopharmacology Series. 4: 95-106. PMID 2839823 DOI: 10.1007/978-3-642-73223-2_8 |
0.442 |
|
| 1987 |
France CP, Adams JU, Woods JH. Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons. Neuropharmacology. 26: 541-8. PMID 3601009 DOI: 10.1016/0028-3908(87)90145-6 |
0.643 |
|
| 1987 |
France CP, Woods JH. Beta-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons. Psychopharmacology. 91: 213-6. PMID 3107034 DOI: 10.1007/Bf00217065 |
0.603 |
|
| 1987 |
Koek W, Woods JH, Jacobson AE, Rice KC. Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP Psychopharmacology. 93: 437-442. PMID 2893414 DOI: 10.1007/Bf00207232 |
0.361 |
|
| 1987 |
Koek W, Woods JH, Ornstein P. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats. Psychopharmacology. 91: 297-304. PMID 2882539 DOI: 10.1007/Bf00518181 |
0.387 |
|
| 1987 |
Woods JH, Winger GD. Behavioral characterization of opioid mixed agonist-antagonists Drug and Alcohol Dependence. 20: 303-315. PMID 2831018 DOI: 10.1016/0376-8716(87)90004-4 |
0.439 |
|
| 1986 |
Dykstra LA, Woods JH. A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. Journal of Pharmacological Methods. 15: 263-9. PMID 3713205 DOI: 10.1016/0160-5402(86)90056-2 |
0.329 |
|
| 1986 |
Koek W, Woods JH. Response repetition in pigeons: pharmacological and behavioral specificity Psychopharmacology. 90: 475-481. PMID 3101104 DOI: 10.1007/Bf00174064 |
0.358 |
|
| 1986 |
Gmerek DE, Woods JH. Kappa receptor mediated opioid dependence in rhesus monkeys Life Sciences. 39: 987-992. PMID 3018406 DOI: 10.1016/0024-3205(86)90287-0 |
0.494 |
|
| 1986 |
Takada K, Winger GD, Cook JA, Larscheid P, Woods JH. Discriminative and aversive properties of β-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkey Life Sciences. 38: 1049-1056. PMID 3005790 DOI: 10.1016/0024-3205(86)90240-7 |
0.318 |
|
| 1986 |
Koek W, Woods JH, Ornstein P. Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate. Life Sciences. 39: 973-8. PMID 2875374 DOI: 10.1016/0024-3205(86)90285-7 |
0.347 |
|
| 1986 |
Young EA, Walker JM, Lewis ME, Houghten RA, Woods JH, Akil H. [3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain. European Journal of Pharmacology. 121: 355-65. PMID 2870933 DOI: 10.1016/0014-2999(86)90256-6 |
0.36 |
|
| 1986 |
Koek W, Kleer E, Mudar PJ, Woods JH. Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate. Behavioural Brain Research. 19: 257-259. PMID 2870725 DOI: 10.1016/0166-4328(86)90026-4 |
0.341 |
|
| 1985 |
France CP, Adams JU, Woods JH. Intracerebroventricular drug administration in pigeons. Pharmacology, Biochemistry, and Behavior. 23: 731-6. PMID 4080758 DOI: 10.1016/0091-3057(85)90063-2 |
0.625 |
|
| 1985 |
Aceto MD, Harris LS, Woods JH, Katz JL, Smith CB, Medzihradsky F, Jacobson AE, Shiotani S. Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans). Japanese Journal of Pharmacology. 39: 7-19. PMID 4068392 DOI: 10.1254/Jjp.39.7 |
0.423 |
|
| 1985 |
Woods JH, Gmerek DE. Substitution and primary dependence studies in animals. Drug and Alcohol Dependence. 14: 233-247. PMID 4039649 DOI: 10.1016/0376-8716(85)90059-6 |
0.501 |
|
| 1985 |
Winger GD, Woods JH. Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding Drug and Alcohol Dependence. 15: 123-130. PMID 4017869 DOI: 10.1016/0376-8716(85)90036-5 |
0.452 |
|
| 1985 |
France CP, Woods JH. Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons. Psychopharmacology. 85: 377-82. PMID 3923525 DOI: 10.1007/Bf00428205 |
0.63 |
|
| 1984 |
Koek W, Woods JH, Rice KC, Jacobson AE, Huguenin PN, Burke TR. Phencyclidine-induced catalepsy in pigeons: specificity and stereoselectivity. European Journal of Pharmacology. 106: 635-638. PMID 6542865 DOI: 10.1016/0014-2999(84)90070-0 |
0.308 |
|
| 1984 |
Herling S, Valentino RJ, Solomon RE, Woods JH. Narcotic discrimination in pigeons: antagonism by naltrexone. European Journal of Pharmacology. 105: 137-42. PMID 6386494 DOI: 10.1016/0014-2999(84)90657-5 |
0.651 |
|
| 1984 |
Medzihradsky F, Dahlstrom PJ, Woods JH, Fischel SV, Mitsos SE. Resolution in the receptor binding of putative μ and κ opiates Life Sciences. 34: 2129-2138. PMID 6145076 DOI: 10.1016/0024-3205(84)90311-4 |
0.365 |
|
| 1984 |
Young AM, Stephens KR, Hein DW, Woods JH. Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. The Journal of Pharmacology and Experimental Therapeutics. 229: 118-26. PMID 6142942 |
0.331 |
|
| 1984 |
Smith CB, Bennett-Kelly L, Woods JH. Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens. Neuropeptides. 5: 161-4. PMID 6099488 DOI: 10.1016/0143-4179(84)90052-0 |
0.377 |
|
| 1983 |
Woods JH. Some thoughts on the relations between animal and human drug-taking Progress in Neuropsychopharmacology and Biological Psychiatry. 7: 577-584. PMID 6686694 DOI: 10.1016/0278-5846(83)90028-3 |
0.323 |
|
| 1983 |
Gmerek DE, Katz JL, France CP, Woods JH. Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys. Life Sciences. 33: 361-4. PMID 6686632 DOI: 10.1016/0024-3205(83)90517-9 |
0.605 |
|
| 1983 |
Valentino RJ, Herling S, Woods JH. Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons. The Journal of Pharmacology and Experimental Therapeutics. 224: 307-13. PMID 6681632 |
0.568 |
|
| 1983 |
Valentino RJ, Katz JL, Medzihradsky F, Woods JH. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists. Life Sciences. 32: 2887-96. PMID 6304445 DOI: 10.1016/0024-3205(83)90325-9 |
0.642 |
|
| 1983 |
Woods JH, Young AM, Medzihradsky F, Smith CB, Aceto MD, Harris LS, Jacobson AE. Zomepirac: preclinical narcotic abuse liability evaluation. Arzneimittel-Forschung. 33: 218-22. PMID 6133523 |
0.357 |
|
| 1982 |
Solomon RE, Herling S, Domino EF, Woods JH. Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys. Neuropharmacology. 21: 1329-36. PMID 7155312 DOI: 10.1016/0028-3908(82)90142-3 |
0.416 |
|
| 1982 |
Falk JL, Schuster CR, Bigelow GE, Woods JH. Progress and needs in the experimental analysis of drug and alcohol dependence. The American Psychologist. 37: 1124-7. PMID 7149427 DOI: 10.1037/0003-066X.37.10.1124 |
0.481 |
|
| 1982 |
Solomon RE, Herling S, Woods JH. Discriminative stimulus effects of monohydroxylated phencyclidine metabolites in Rhesus monkeys. European Journal of Pharmacology. 82: 233-7. PMID 7128690 DOI: 10.1016/0014-2999(82)90520-9 |
0.381 |
|
| 1982 |
Bertalmio AJ, Herling S, Hampton RY, Winger G, Woods JH. A procedure for rapid evaluation of the discriminative stimulus effects of drugs Journal of Pharmacological Methods. 7: 289-299. PMID 7121010 DOI: 10.1016/0160-5402(82)90082-1 |
0.308 |
|
| 1982 |
Young AM, Woods JH. Limitations on the antagonistic actions of opioid antagonists. Federation Proceedings. 41: 2333-8. PMID 7042396 |
0.396 |
|
| 1982 |
Woods JH, Young AM, Herling S. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Federation Proceedings. 41: 221-7. PMID 7037459 |
0.381 |
|
| 1982 |
Katz JL, Woods JH, Winger GD, Jacobson AE. Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys. Life Sciences. 31: 2375-8. PMID 6298529 DOI: 10.1016/0024-3205(82)90160-6 |
0.376 |
|
| 1982 |
Herling S, Hein DW, Nemeth MA, Valentino RJ, Woods JH. Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action. Life Sciences. 30: 331-41. PMID 6122153 DOI: 10.1016/0024-3205(82)90569-0 |
0.63 |
|
| 1982 |
Woods JH. Benzodiazepine dependence studies in animals: An overview Drug Development Research. 2: 77-81. DOI: 10.1002/Ddr.430010712 |
0.309 |
|
| 1981 |
Woods JH, Schuster CR, Hartel CR. Behavioral effects of thebaine in the rhesus monkey. Pharmacology, Biochemistry, and Behavior. 14: 805-9. PMID 7255516 DOI: 10.1016/0091-3057(81)90364-6 |
0.612 |
|
| 1981 |
Valentino RJ, Herling S, Woods JH. The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings]. Psychopharmacology Bulletin. 17: 51-4. PMID 7195052 |
0.503 |
|
| 1981 |
Valentino RJ, Smith CB, Woods JH. Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome. Federation Proceedings. 40: 1502-7. PMID 7194193 |
0.592 |
|
| 1981 |
Young AM, Swain HH, Woods JH. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys. Psychopharmacology. 74: 329-35. PMID 6794076 DOI: 10.1007/BF00432741 |
0.795 |
|
| 1981 |
Herling S, Woods JH. Discriminative stimulus effects of etorphine in Rhesus monkeys. Psychopharmacology. 72: 265-267. PMID 6784144 DOI: 10.1007/Bf00431828 |
0.421 |
|
| 1981 |
Young AM, Katz JL, Woods JH. Behavioral effects of levonantradol and nantradol in the rhesus monkey. Journal of Clinical Pharmacology. 21: 348S-360S. PMID 6271836 DOI: 10.1002/J.1552-4604.1981.Tb02614.X |
0.793 |
|
| 1981 |
Herling S, Woods JH. Iv. Discriminative Stimulus Effects Of Narcotics: Evidence For Multiple Receptor-Mediated Actions Life Sciences. 28: 1571-1584. PMID 6264253 DOI: 10.1016/0024-3205(81)90311-8 |
0.464 |
|
| 1981 |
Valentino RJ, Herling S, Woods JH, Medzihradsky F, Merz H. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists. The Journal of Pharmacology and Experimental Therapeutics. 217: 652-9. PMID 6262493 |
0.577 |
|
| 1981 |
Woods JH, Herling S, Young AM. Comparison of discriminative and reinforcing stimulus characteristics of morphine-like opioids and two met-enkephalin analogues Neuropeptides. 1: 409-419. DOI: 10.1016/0143-4179(81)90039-1 |
0.785 |
|
| 1981 |
Herling S, Coale EH, Hein DW, Winger G, Woods JH. Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon Psychopharmacology. 73: 286-291. DOI: 10.1007/BF00422419 |
0.34 |
|
| 1980 |
Herling S, Coale EH, Valentino RJ, Hein DW, Woods JH. Narcotic discrimination in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 214: 139-46. PMID 6993656 |
0.444 |
|
| 1980 |
Abelson JS, Woods JH. Effects of apomorphine on elicited and operant pecking in pigeons. Psychopharmacology. 71: 237-241. PMID 6779332 DOI: 10.1007/Bf00433057 |
0.362 |
|
| 1980 |
Young AM, Woods JH. Behavior maintained by intravenous injection of codeine, cocaine, and etorphine in the rhesus macaque and the pigtail macaque. Psychopharmacology. 70: 263-71. PMID 6777798 DOI: 10.1007/BF00427883 |
0.795 |
|
| 1980 |
Moody DB, Winger G, Woods JH, Stebbins WC. Effect of ethanol and of noise on reaction time in the monkey: variation with stimulus level. Psychopharmacology. 69: 45-51. PMID 6771825 DOI: 10.1007/Bf00426520 |
0.303 |
|
| 1980 |
Woods JH. Narcotic-reinforced responding: A rapid evaluation procedure Drug and Alcohol Dependence. 5: 223-230. PMID 6766377 DOI: 10.1016/0376-8716(80)90182-9 |
0.352 |
|
| 1979 |
Valentino RJ, Smith CB, Woods JH. An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum. Nature. 281: 370-2. PMID 225676 DOI: 10.1038/281370A0 |
0.619 |
|
| 1979 |
Woods JH, Herling S, Valentino RJ, Hein DW, Coale EH. Narcotic drug discriminations by rhesus monkeys and pigeons. Nida Research Monograph. 27: 128-34. PMID 121328 |
0.484 |
|
| 1979 |
Herling S, Downs DA, Woods JH. Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys Psychopharmacology. 64: 261-269. PMID 116268 DOI: 10.1007/BF00427508 |
0.445 |
|
| 1978 |
Tessel RE, Woods JH. meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships. The Journal of Pharmacology and Experimental Therapeutics. 205: 274-81. PMID 417172 |
0.599 |
|
| 1978 |
Tepper P, Woods JH. Changes in locomotor activity and naloxone-induced jumping in mice produced by WIN 35, 197-2 (ethylketazocine) and morphine. Psychopharmacology. 58: 125-129. PMID 98778 DOI: 10.1007/Bf00426894 |
0.51 |
|
| 1978 |
Karoly AJ, Winger G, Ikomi F, Woods JH. The reinforcing property of ethanol in the rhesus monkey - II. Some variables related to the maintenance of intravenous ethanol-reinforced responding Psychopharmacology. 58: 19-25. PMID 97716 DOI: 10.1007/Bf00426785 |
0.306 |
|
| 1976 |
Carney JM, Llewellyn ME, Woods JH. Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey. Pharmacology, Biochemistry, and Behavior. 5: 577-52. PMID 828270 DOI: 10.1016/0091-3057(76)90272-0 |
0.359 |
|
| 1976 |
Llewellyn ME, Iglauer C, Woods JH. Relative reinforcer magnitude under a nonindependent concurrent schedule of cocaine reinforcement in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 25: 81-91. PMID 814191 DOI: 10.1901/jeab.1976.25-81 |
0.418 |
|
| 1975 |
Downs DA, Woods JH. Fixed ratio escape and avoidance escape from naloxone in morphine dependent monkeys: effects of naloxone dose and morphine pretreatment Journal of the Experimental Analysis of Behavior. 23: 415-427. PMID 1170272 DOI: 10.1901/Jeab.1975.23-415 |
0.426 |
|
| 1975 |
Downs DA, Woods JH. Food- and drug-reinforced responding: Effects of DITA and d-amphetamine Psychopharmacologia. 43: 13-17. PMID 1161990 DOI: 10.1007/BF00437608 |
0.369 |
|
| 1975 |
Tessel RE, Woods JH, Counsell RE, Basmadjian GP. Structure-activity relationships between meta-substituted N-ethylamphetamines and isolated guinea-pig atrial rate. The Journal of Pharmacology and Experimental Therapeutics. 192: 319-26. PMID 1117419 |
0.616 |
|
| 1975 |
Tessel RE, Woods JH, Counsell RE, Lu M. Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice. The Journal of Pharmacology and Experimental Therapeutics. 192: 310-8. PMID 1117418 |
0.644 |
|
| 1975 |
Winger G, Stitzer ML, Woods JH. Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 195: 505-14. PMID 811787 |
0.516 |
|
| 1975 |
Tessel RE, Woods JH. Fenfluramine and N-ethyl amphetamine: comparison of the reinforcing and rate-decreasing actions in the rhesus monkey. Psychopharmacologia. 43: 239-44. PMID 810821 DOI: 10.1007/BF00429257 |
0.696 |
|
| 1975 |
Rosenberg J, Woods JH. Effects of pentobarbital on fixed-ratio discrimination* Bulletin of the Psychonomic Society. 5: 33-35. DOI: 10.3758/Bf03336692 |
0.348 |
|
| 1974 |
Iglauer C, Woods JH. Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 22: 179-196. PMID 4455758 DOI: 10.1901/Jeab.1974.22-179 |
0.415 |
|
| 1974 |
Woods JH, Tessel RE. Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey. Science (New York, N.Y.). 185: 1067-9. PMID 4212011 DOI: 10.1126/Science.185.4156.1067 |
0.702 |
|
| 1971 |
Goldberg SR, Woods JH, Schuster CR. Nalorphine-induced changes in morphine self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 176: 464-71. PMID 4998693 |
0.542 |
|
| 1969 |
Goldberg SR, Woods JH, Schuster CR. Morphine: conditioned increases in self-administration in rhesus monkeys. Science (New York, N.Y.). 166: 1306-7. PMID 4981723 DOI: 10.1126/Science.166.3910.1306 |
0.634 |
|
| 1968 |
Woods JH, Schuster CR. Reinforcement Properties of Morphine, Cocaine, and SPA as a Function of Unit Dose International Journal of the Addictions. 3: 231-237. DOI: 10.3109/10826086809042898 |
0.645 |
|
| 1968 |
Schuster CR, Woods JH. The Conditioned Reinforcing Effects of Stimuli Associated with Morphine Reinforcement International Journal of the Addictions. 3: 223-230. DOI: 10.3109/10826086809042897 |
0.578 |
|
| 1966 |
Schuster CR, Dockens WS, Woods JH. Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia. 9: 170-82. PMID 5983915 DOI: 10.1007/Bf00404721 |
0.6 |
|
| 1966 |
Schuster CR, Woods JH. Schedule-induced polydipsia in the rhesus monkey. Psychological Reports. 19: 823-8. PMID 4963005 DOI: 10.2466/pr0.1966.19.3.823 |
0.507 |
|
| Show low-probability matches. |